Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Hyperglycemia and glycemic control in critically ill and hospitalized patients

TopicLeading institutions, researchers & key papers

This cluster of papers explores the impact of hyperglycemia, the use of intensive insulin therapy, and glycemic control on health outcomes in critically ill and surgical patients, with a focus on infection risk, mortality, and the inflammatory response. It also investigates the association between hyperglycemia and various medical conditions such as myocardial infarction, stroke, and traumatic brain injury.

350
Works

How has Hyperglycemia and glycemic control in critically ill and hospitalized patients's publication output changed over time?

ScholarIQpublication output · 1995–2015

Output grew0% over the shown period — from 1 works in 1995 to 1 in 2015.

1
1
1
4
1
3
2
1
1
199520032004200520072008200920122015

What are the most-cited papers on Hyperglycemia and glycemic control in critically ill and hospitalized patients?

ScholarIQmost cited works
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
William C. Duckworth, Carlos Abraira, Thomas Moritz, Domenic J. Reda, Nicholas Emanuele, Peter D. Reaven, Franklin J. Zieve, Jennifer A. Marks, Stephen N. Davis, Rodney A. Hayward, Stuart Warren, Steven Goldman, Madeline McCarren, Mary Ellen Vitek, William G. Henderson, Grant D. Huang
New England Journal of Medicine. 20084,791 CitationsOPEN ACCESS
Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis
Frank M. Brunkhorst, Christoph Engel, Frank Bloos, Andreas Meier‐Hellmann, Max Ragaller, Norbert Weiler, Onnen Moerer, Matthias Gruendling, Michael Oppert, Stefan Grond, D Olthoff, Ulrich Jaschinski, Stefan John, Rolf Rossaint, Tobias Welte, Martin Schaefer, Peter Kern, Evelyn Kuhnt, Michael Kiehntopf, Christiane S. Hartog, Charles Natanson, Markus Loeffler, Konrad Reinhart
New England Journal of Medicine. 20082,935 CitationsOPEN ACCESS
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
Klas Malmberg, Lars Rydén, Suad Efendić, Johan Herlitz, Peter Nicol, Anders Waldenström, Hans Wedel, Lennart Welin
Journal of the American College of Cardiology. 19951,577 CitationsOPEN ACCESS
American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Etie S. Moghissi, Mary T. Korytkowski, Monica M. DiNardo, Daniel Einhorn, Richard Hellman, Irl B. Hirsch, Silvio E. Inzucchi, Faramarz Ismail‐Beigi, M. Sue Kirkman, Guillermo E. Umpierrez
Diabetes Care. 20091,456 CitationsOPEN ACCESS
Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline
Guillermo E. Umpierrez, Richard Hellman, Mary T. Korytkowski, Mikhail Kosiborod, Gregory A. Maynard, Víctor M. Montori, Jane Jeffrie Seley, Greet Van den Berghe
The Journal of Clinical Endocrinology & Metabolism. 20121,126 CitationsOPEN ACCESS

Where is Hyperglycemia and glycemic control in critically ill and hospitalized patients research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Hyperglycemia and glycemic control in critically ill and hospitalized patients is open access?

ScholarIQopen access share
73%OPEN ACCESS
Gold
7%
Green
0%
Hybrid
13%
Bronze
53%
Closed
27%

Related on ScholarIQ

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Paper
Effects of Intensive Glucose Lowering in Type 2 Diabetes
Paper
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
Paper
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Paper
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Paper
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Paper
470M+ articles · free account